2018
DOI: 10.1097/sap.0000000000001589
|View full text |Cite
|
Sign up to set email alerts
|

The Stromal Vascular Fraction Improves Maintenance of the Fat Graft Volume

Abstract: Most studies found a significant and measurable long-term effect of SVF-enhanced fat grafting on breast augmentation and defects, wound healing, scaring, and facial aesthetic outcomes. Stromal vascular fraction use did not result in a higher instance of complications and, thus, can be considered a safe option for fat grafting.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(21 citation statements)
references
References 32 publications
1
17
0
3
Order By: Relevance
“…Therefore, the key to fat regeneration is to increase the content of SVF cells and ASCs. At present, the cell-assisted fat transplantation technology Lipotransfer involves the addition of regenerated cells (ASCs or SVF cells), which has proven to significantly improve the retention rate of fat grafts in small-scale fat transplantation (Zhang et al, 2016;Zhou et al, 2016;Gontijode-Amorim et al, 2017;Li et al, 2017;Cai et al, 2018;Bashir et al, 2019;Hong et al, 2019;Kim et al, 2019). However, this technology is limited based on safety challenges such as enzyme digestion, contamination, and possible promotion of tumor recurrence in the process of regeneration related to the steps of cell separation; these have hindered its clinical use (Fraser et al, 2011;Krumboeck et al, 2013;Orbay et al, 2018;Gebremeskel et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the key to fat regeneration is to increase the content of SVF cells and ASCs. At present, the cell-assisted fat transplantation technology Lipotransfer involves the addition of regenerated cells (ASCs or SVF cells), which has proven to significantly improve the retention rate of fat grafts in small-scale fat transplantation (Zhang et al, 2016;Zhou et al, 2016;Gontijode-Amorim et al, 2017;Li et al, 2017;Cai et al, 2018;Bashir et al, 2019;Hong et al, 2019;Kim et al, 2019). However, this technology is limited based on safety challenges such as enzyme digestion, contamination, and possible promotion of tumor recurrence in the process of regeneration related to the steps of cell separation; these have hindered its clinical use (Fraser et al, 2011;Krumboeck et al, 2013;Orbay et al, 2018;Gebremeskel et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Дослідження стосувались використання СВФ задля покращення якості шкіри, лікування ран та шрамів, колінного остеоартриту, ахілесової тендинопатії, розладів скроневонижньощелепного суглоба, перианального свища, спричиненого хворобою Крона чи локальною радіотерапією, рубців голосових зв'язок, васкулопатії, андрогенної алопеції, мігрені, діабету, розсіяного склерозу, опіків, проблем із центральною нервовою системою, створення імплантів кісток та полегшення проблем із центральною нервовою системою і опорно-руховим апаратом [11,12,13].…”
Section: іі розвиток застосування свф як джерела стовбурових клітин для регенеративної медициниunclassified
“…In addition to that, the lipoaspirate can be used in combination with other biological products. These include cell assisted lipo lling (CAL), where fat is combined with adipose-derived stem cells (ADSC) which have been reported to improve fat survival rate (4), ADSC transfer only, fat plus stromal vascular fraction (SVF) transfer, which contains ADSC's, endothelial cells, endothelial progenitor cells, pericytes, preadipocytes and hematopoietic cells (5) and fat plus platelet rich plasma (PRP), which is claimed to support angiogenesis and reduce absorption of fat (6,7).…”
Section: Prospero Registration Number: Crd42020213407mentioning
confidence: 99%